Literature DB >> 8548331

Evaluation of four alternative methodologies for determination of absolute CD4+ lymphocyte counts. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.

D Johnson1, D Hirschkorn, M P Busch.   

Abstract

Standard methods for determining absolute CD3+CD4+ T-lymphocyte concentrations using combined results from flow cytometry and hematology analyzers are expensive and require fresh (< 18 h old) blood. We evaluated four new "alternative" methods for determining absolute CD4+ T-lymphocyte counts; (a) the FACSCount System (Becton Dickinson Immunocytometry Systems), (b) VCS Technology/Coulter Cyto-Spheres (Coulter Corporation), (c) Zymmune CD4/CD8 Cell Monitoring Kit (Zynaxis, Inc.), and (d) TRAx CD4 Test Kit (T Cell Diagnostics). EDTA-anticoagulated whole-blood specimens from HIV-seropositive patients and anti-HIV-negative adult blood donors and staff were tested by the standard flow cytometry method on fresh blood (0-6 postphlebotomy) and by the four alternative methods at 0 to 6 h and 24 to 30 h postphlebotomy. Representative specimens (< 6 h old) were tested five times with each system to evaluate reproducibility. Correlation coefficients for absolute CD4+ counts between standard flow cytometry and the alternative methods ranged from 0.84 to 0.92 for both fresh and 24- to 30-h-old specimens. Average coefficient of variation for reproducibility ranged from 4.5 to 7.1%. The four alternative CD4+ T-lymphocyte counting methods performed well relative to standard methods. Each alternative method offers advantages over standard flow cytometry with respect to sample throughout, required technical expertise, and cost per result. These methods should facilitate wider availability of low-cost CD4 counts.

Entities:  

Mesh:

Year:  1995        PMID: 8548331

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  10 in total

1.  Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group.

Authors:  K A Reimann; M R O'Gorman; J Spritzler; C L Wilkening; D E Sabath; K Helm; D E Campbell
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Clinical field site evaluation of the FACSCount for absolute CD3+, CD3+ CD4+, and CD3+ CD8+ cell count determinations in Thailand.

Authors:  N L Young; P Ponglertnapakorn; N Shaffer; K Srisak; T Chaowanachan; V On-Thern; C Kittinunvorakoon; A Bunwattanakul; S Suksaweang; V Pobkeeree; J Punnotok; T D Mastro
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

3.  Evaluation of a method for counting absolute numbers of cells with a flow cytometer.

Authors:  J K Nicholson; D Stein; T Mui; R Mack; M Hubbard; T Denny
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

4.  Inter- and intrainstitutional evaluation of automated volumetric capillary cytometry for the quantitation of CD4- and CD8-positive T lymphocytes in the peripheral blood of persons infected with human immunodeficiency virus. Site Investigators and the NIAID New CD4 Technologies Focus Group.

Authors:  M R O'Gorman; R Gelman
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

5.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

6.  Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy.

Authors:  Fred Lutwama; Ronnie Serwadda; Harriet Mayanja-Kizza; Hasan M Shihab; Allan Ronald; Moses R Kamya; David Thomas; Elizabeth Johnson; Thomas C Quinn; Richard D Moore; Lisa A Spacek
Journal:  J Acquir Immune Defic Syndr       Date:  2008-07-01       Impact factor: 3.731

Review 7.  CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Authors:  Rosanna W Peeling; Kimberly A Sollis; Sarah Glover; Suzanne M Crowe; Alan L Landay; Ben Cheng; David Barnett; Thomas N Denny; Thomas J Spira; Wendy S Stevens; Siobhan Crowley; Shaffiq Essajee; Marco Vitoria; Nathan Ford
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

8.  Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.

Authors:  Edward Kumakech; Vanja Berggren; Henry Wabinga; Gabriella Lillsunde-Larsson; Gisela Helenius; Malin Kaliff; Mats Karlsson; Samuel Kirimunda; Caroline Musubika; Sören Andersson
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

9.  Epidemiological characteristics and adherence of a cohort of elderly people with HIV/AIDS in the Public Health System.

Authors:  Cristiane Marcos Soares Dias Ferreira; Isabel Cristina Gonçalves Leite
Journal:  Einstein (Sao Paulo)       Date:  2022-03-25

10.  Higher pre-infection vitamin E levels are associated with higher mortality in HIV-1-infected Kenyan women: a prospective study.

Authors:  Susan M Graham; Jared M Baeten; Barbra A Richardson; Daniel D Bankson; Ludo Lavreys; Jeckoniah O Ndinya-Achola; Kishorchandra Mandaliya; Julie Overbaugh; R Scott McClelland
Journal:  BMC Infect Dis       Date:  2007-06-26       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.